Stockreport

This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know [Yahoo! Finance]

Viridian Therapeutics, Inc.  (VRDN) 
PDF 2,957,386 shares in the fourth quarter, an estimated $81.11 million transaction based on quarterly average pricing, according to a February 17, 2026, SEC filing. What [Read more]